东方证券:降脂药市场规模预计十年后将达465.8亿美元 国产药物占据主导地位

财中社
12 Feb

财中社2月12日电东方证券发表研究报告称:全球心血管疾病发病率上升,推动降脂药市场稳定增长。从全球来看,2023年降脂药市场规模为331.2亿美元,预计十年后将达到465.8亿美元,期间CAGR 3.45%。而从国内市场看,血脂异常和心血管疾病死亡率逐年提升,且趋于年轻化,我国18岁以上人群血脂异常患病率已上升至40.4%。2023年,我国等级医院及零售终端降脂药销售额已突破250亿元,未来有望...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10